Sep 01, 09:09
Sep 01, 09:07
Dr Reddys Labs
69% of moneycontrol users recommend buying Dr Reddys Labs.
What's your call on Dr Reddys Labs today?
Read 10 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2988.00||1.25||2989.80||2286.80||50,896.11|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
IFGL Refractories Recommended on May 28th 2014
Recommended price 114.00 | Peak from reco 209.00 83.01%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Dr Reddys Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 50,779.43 crore.The company has reported a consolidated sales of Rs 3,480.90 crore and a Net Profit of Rs 476.76 crore for the quarter ended Mar 2014.
The company management includes Satish Reddy - Chairman, G V Prasad - Co-Chairman & Manag. Director, Anupam Puri - Independent Director, Ashok S Ganguly - Independent Director, Bruce L A Carter - Independent Director, J P Moreau - Independent Director, Sridar Iyengar - Independent Director, Kalpana Morparia - Independent Director, Ravi Bhoothalingam - Independent Director, Omkar Goswami - Independent Director.
It is listed on the BSE with a BSE Code of 500124 and the NSE with an NSE Code of DRREDDY.
Its Registered office is at 8-2-337, Road No. 3,,Banjara Hills Hyderabad,Telangana - 500034.
Their Registrars are Bigshare Services Pvt. Ltd.